Overview
Autoimmune Polyglandular Syndrome type 2 (APS-2) is characterized by the association of Addison's disease (primary adrenal insufficiency), autoimmune thyroid disease, and often type 1 diabetes mellitus, along with potential involvement of other endocrine and non-endocrine organs 1.Diagnosis
Key Diagnostic Criteria: Presence of Addison's disease and autoimmune thyroid disease, frequently accompanied by type 1 diabetes mellitus 1.
Recommended Tests:
- Adrenal function tests (cortisol, ACTH stimulation test)
- Thyroid function tests (TSH, free T4)
- Autoantibody screening (21-hydroxylase, TPO, GAD)
Grading: Diagnosis often made retrospectively with a latency period observed in many patients 1.Management
First-Line Treatments:
- Glucocorticoids and mineralocorticoids for adrenal insufficiency 1.
- Levothyroxine for hypothyroidism 1.
- Insulin for type 1 diabetes 1.
Adjunctive Treatments:
- Vitamin D supplementation due to frequent deficiencies and low bone mineral density 2.
- Hydroxycobalamin as an alternative to cyanocobalamin in cases of hypersensitivity reactions 3.Special Populations
Bone Health: Patients with APS-2 have significantly lower bone mineral density and vitamin D levels, necessitating monitoring and supplementation 2.
Hypersensitivity Reactions: Consider alternative forms of vitamin B12 (e.g., hydroxycobalamin) in patients with known hypersensitivity to cyanocobalamin 3.Key Recommendations
Regular monitoring of multiple endocrine functions and bone health is essential due to the multisystem involvement in APS-2 (Evidence: Moderate 12).
Vitamin D supplementation should be considered to address deficiencies and mitigate bone density issues observed in APS-2 patients (Evidence: Moderate 2).
In managing APS-2 patients with suspected B12 deficiency, assess for hypersensitivity to cyanocobalamin and consider hydroxycobalamin as an alternative (Evidence: Weak 3).References
1 Gatta E, Maltese V, Cimino E, Cavadini M, Anelli V, Di Lodovico E et al.. Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications. Journal of endocrinological investigation 2024. link
2 Akkurt Kocaeli A, Erturk E. Bone Mineral Density and Vitamin D Status in Patients with Autoimmune Polyglandular Syndromes: A Single Tertiary Care Center Experience. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2024. link
3 Moloney FJ, Hughes R, O'Shea D, Kirby B. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin. Clinical and experimental dermatology 2008. link